Paradigm

New Partnership Announcement: Paradigm & ARC Innovation at Sheba Medical Center, Tel Hashomer has announced a strategic partnership with Paradigm to establish a global network for clinical research. “Partnering with Paradigm allows us to leverage cutting-edge technologies to create a unified global network that standardizes and optimizes clinical trials, ensuring that life-saving treatments reach patients faster and more efficiently. Our co-development of the clinical trial platform of the future aligns with ARC’s mission to transform global health through innovation. With Paradigm’s cutting-edge platform, we can accelerate the pace of innovation and bring life-saving treatments to patients faster than ever before,” said Professor Eyal Zimlichman, MD, Chief Innovation and Transformation Officer at Sheba Medical Center, Tel Hashomer and Founder and Director of ARC Innovation This collaboration aims to revolutionize the way clinical trials are conducted, making them more accessible, efficient, and patient-centered. Kent Thoelke 🏳️🌈 Jonathan Hirsch Stephen Klasko Shachar Orpaz Ariel Weiss Eyal Zimlichman, MD Daphna Deane Angel W. Rabinovich Benny Ben Lulu Gal Goshen Avi (Abraham) Tsur, MD Avner Halperin Orli Biger Number 10 Strategies LLP Raoul Wootliff Gideon Spicer-Bratt Shani Jaffe Joshua Hantman https://lnkd.in/dJPtxm2s

We're thrilled to announce a landmark collaboration that's set to transform the landscape of clinical research: Sheba's ARC Innovation has partnered with Paradigm Health Inc. to develop an AI-driven platform that will revolutionize how clinical trials are conducted worldwide! This initiative aligns with Sheba's commitment to becoming one of the world's first fully AI-integrated hospitals, setting new standards for global healthcare innovation. Find out more about the collaboration here: https://lnkd.in/dp53RHwh #HealthcareInnovation #ClinicalTrials #ArtificialIntelligence #MedicalResearch #GlobalHealthcare

Our leadership team is in Israel today announcing a groundbreaking partnership with Sheba Medical Center, Tel Hashomer and ARC Innovation. We are honored to be part of this announcement highlighting Sheba’s ongoing leadership in #clinicaltrials and the role Paradigm will play in supporting the scaling of clinical trials throughout Israel, and the development of a global clinical trials network with Sheba and ARC. Sheba Medical Center is Israel's largest hospital and a well-established leader in clinical trials. Through the deployment of our platform, we will help extend Sheba’s reach, efficiency, and capabilities across Sheba and their affiliated clinics. We’ll be collaborating to streamline trial operations, including feasibility assessments, patient screening, recruitment, and data collection. Sheba is a hugely in-demand location for biopharma trials, and our work together will expand their capacity by lowering the administrative burden of trials. That means more patients will have access to innovative treatments, and providers will be able to spend more time focusing on patient care rather than paperwork. We're grateful for the trust of ARC Innovation and Sheba Medical Center, and honored to help serve their patients. From Israel to Japan to North Dakota and beyond, we're building a new, end-to-end clinical trials platform and changing the paradigm for patient care and clinical trial access globally. Read more: https://lnkd.in/enaTjx9j

I’m in Tel Aviv today announcing a groundbreaking partnership with Sheba Medical Center, Tel Hashomer and ARC Innovation and Paradigm Health. It was an honor to be part of this announcement in person today with Eyal Zimlichman, MD, CITO Sheba Medical Center/Director ARC Innovation, Stephen Klasko, Board Member, Paradigm Health and Jonathan Hirsch, Chief Strategy Officer, Paradigm Health. Today at a signing ceremony, we highlighted Sheba’s ongoing leadership in clinical trials and the role Paradigm Health will play in supporting the scaling of clinical trials throughout Israel, and the development of a global clinical trials network with Sheba and ARC.  Sheba Medical Center is Israel's largest hospital and a well-established leader globally in clinical trials. Through the deployment of the Paradigm Health platform, we will help extend Sheba’s reach, efficiency, and capabilities across Sheba and their affiliated clinics. We will be collaborating to streamline trial operations, including feasibility assessments, patient screening, recruitment, and data collection.  Sheba is widely used as a location for biopharma clinical trials, and our work together will expand their capacity by lowering the administrative burden of trials. That means more patients will have access to clinical trials, innovative treatments, and providers will be able to spend more time focusing on patient care rather than paperwork.  We're grateful for the trust of ARC Innovation and Sheba Medical Center, and honored to help serve their patients. From Israel to Japan to North Dakota and beyond, we're building a new, end-to-end clinical trials platform and changing the paradigm for patient care and clinical trial access globally. https://lnkd.in/gttXXfq3

Today Florida Cancer Specialists & Research Institute (FCS) announced a groundbreaking partnership with Paradigm Health. We’re so proud to be partnering with FCS and providing support for their work. This collaboration is an impactful and critical step forward in expanding equitable patient access to clinical trials across Florida. For patients and providers at FCS's extensive network of 33 early and late-phase research locations, Paradigm Health's powerful technology platform will streamline the planning, recruitment, and conduct of trials. Our work together will make it easier for more patients to have access to important treatment and care options, and for providers to be able to spend more time focusing on direct patient care rather than administration. For biopharma trial sponsors, this means the ability to bring trials directly to patients across Florida at scale, and recruit a more diverse set of patients to assure a more representative population for your trials. We’re grateful for the trust of Florida Cancer Specialists, and honored to help serve their patients. From Florida to Japan to North Dakota and beyond, we’re building a new, end-to-end clinical trials platform and changing the paradigm for patient care and clinical trial access. https://lnkd.in/ghsGTPd6

Today Florida Cancer Specialists & Research Institute announced a groundbreaking partnership with Paradigm. We’re so proud to support their work. This collaboration will be a big step forward in expanding patient access to clinical trials across Florida. For patients and providers at FCS's extensive network of 33 early and late-phase research locations, Paradigm's powerful technology platform will streamline the planning, recruitment, and conduct of trials. Our work together will make it easier for more patients to have access to important treatment options, and for providers to focus on direct patient care rather than administration. For biopharma trial sponsors, this means the ability to bring trials directly to patients across Florida, and recruit diverse patients to assure the representatives of your trials. We’re grateful for the trust of Florida Cancer Specialists, and honored to help serve their patients. From Florida to Japan to North Dakota and beyond, we’re building an end-to-end new clinical trials platform and changing the paradigm for patient care. https://lnkd.in/eGMD5B_m

Today I am thrilled to announce Paradigm’s international expansion to Japan! It was an honor to announce this collaboration in Tokyo today with Fujitsu, Japan’s leading EHR and digital health provider, where we shared the details of our partnership. This collaboration supports our shared vision of creating a more equitable, accessible and efficient clinical trial ecosystem, not just for those in the US, but with aligned partners globally. The implementation and integration of our platform and Fujitsu’s EHR will rapidly increase both patient recruitment into clinical trials while maximizing trial efficiency in Japan.   🏥 For physicians and medical institutions in Japan, Paradigm working with Fujitsu means the ability to participate in more trials without increasing workload. This is the future of clinical research - where technology empowers healthcare efficiency and enables providers to offer more options to their patients with less burden. 🙏🏻 My deep gratitude to the Japanese health officials, physicians and researchers who attended our press conference today. Your support and commitment for a more inclusive healthcare future for patients in Japan are what will make this a success. Here's to faster drug development, more equitable patient access to clinical trials, and a healthier world. https://lnkd.in/gxx9uFnP

Paradigm is pleased to announce the results of our work with Highlands Oncology Group, which has achieved a remarkable 45% increase in patients enrolled in trials using our platform. Paradigm is also bringing new phase I - III interventional therapeutic clinical trial opportunities from biopharma sponsors tailored to Highlands’ local patient population and capabilities, increasing patient access to cutting edge therapy options. Read more in our case study, published today: https://lnkd.in/gNfrYJna Thank you to Highlands for trusting us with this important work, and congratulations on increasing access to high quality care for your patients.

Paradigm is growing and we continue to impact cancer care today, by creating more equitable and systemic access to therapeutic clinical trials. We are currently hiring for an exciting addition to our team for an Executive Medical Director with an oncology background to work collaboratively across the company to support our vision to create a new clinical trial paradigm. We are looking for an innovative physician/researcher who not only excels in current treatment paradigms but has a passion for data and medical informatics and is looking break the status quo and help us build a new future for clinical trials. If you are interested in joining me and our phenomenal team please reach out and apply via the link or the posting below - https://lnkd.in/gTxU7ajx. If you know of candidates that you think would be a great fit and want to refer - please reach out to me!

As a rural health system, our patients deserve the best care close to home. We are excited to partner with Paradigm to get our patients the care they deserve. 💚   "Patients in rural communities face geographic and socioeconomic burdens that inhibit access to novel treatments. It is imperative that we expand patient access to research through community health systems," said Altru Research Program Manager Ashlee Dagoberg, PT, DPT.”